BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30179653)

  • 1. Novel peptide inhibitor of dipeptidyl peptidase IV (Tyr-Pro-D-Ala-NH
    Salaga M; Binienda A; Draczkowski P; Kosson P; Kordek R; Jozwiak K; Fichna J
    Peptides; 2018 Oct; 108():34-45. PubMed ID: 30179653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration.
    Salaga M; Mokrowiecka A; Zielinska M; Malecka-Panas E; Kordek R; Kamysz E; Fichna J
    J Pharmacol Exp Ther; 2017 Oct; 363(1):92-103. PubMed ID: 28724693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis.
    Mimura S; Ando T; Ishiguro K; Maeda O; Watanabe O; Ujihara M; Hirayama Y; Morise K; Maeda K; Matsushita M; Funasaka K; Nakamura M; Miyahara R; Ozaki N; Goto H
    Scand J Gastroenterol; 2013 Oct; 48(10):1152-9. PubMed ID: 24047394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
    Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides from dietary proteins.
    Nongonierma AB; FitzGerald RJ
    J Food Biochem; 2019 Jan; 43(1):e12451. PubMed ID: 31353485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptidyl peptidase 4 inhibitor sitagliptin protected against dextran sulfate sodium-induced experimental colitis by potentiating the action of GLP-2.
    Ning MM; Yang WJ; Guan WB; Gu YP; Feng Y; Leng Y
    Acta Pharmacol Sin; 2020 Nov; 41(11):1446-1456. PubMed ID: 32398684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonic inflammation induces changes in glucose levels through modulation of incretin system.
    Zatorski H; Salaga M; Zielińska M; Mokrowiecka A; Jacenik D; Krajewska WM; Małecka-Panas E; Fichna J
    Pharmacol Rep; 2021 Dec; 73(6):1670-1679. PubMed ID: 34535873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DPP-IV inhibitor ER-319711 has a proliferative effect on the colonic epithelium and a minimal effect in the amelioration of colitis.
    Ban H; Bamba S; Imaeda H; Inatomi O; Kobori A; Sasaki M; Tsujikawa T; Andoh A; Fujiyama Y
    Oncol Rep; 2011 Jun; 25(6):1699-703. PubMed ID: 21431278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory role of DPP-4 inhibitors in a nondiabetic model of glomerular injury.
    Higashijima Y; Tanaka T; Yamaguchi J; Tanaka S; Nangaku M
    Am J Physiol Renal Physiol; 2015 Apr; 308(8):F878-87. PubMed ID: 25656369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic and phytocompounds based dipeptidyl peptidase-IV (DPP-IV) inhibitors for therapeutics of diabetes.
    Singh AK; Jatwa R; Purohit A; Ram H
    J Asian Nat Prod Res; 2017 Oct; 19(10):1036-1045. PubMed ID: 28351157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice.
    Waget A; Cabou C; Masseboeuf M; Cattan P; Armanet M; Karaca M; Castel J; Garret C; Payros G; Maida A; Sulpice T; Holst JJ; Drucker DJ; Magnan C; Burcelin R
    Endocrinology; 2011 Aug; 152(8):3018-29. PubMed ID: 21673098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.
    Singh S; Roy S; Sethi S; Benjamin B; Sundaram S; Khanna V; Kandalkar SR; Pal C; Kant R; Patra AK; Rayasam G; Mittra S; Saini KS; Paliwal J; Chugh A; Ahmed S; Sattigeri J; Cliff I; Ray A; Bansal VS; Bhatnagar PK; Davis JA
    Eur J Pharmacol; 2011 Feb; 652(1-3):157-63. PubMed ID: 20540938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
    Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
    Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptidyl peptidase expression during experimental colitis in mice.
    Yazbeck R; Sulda ML; Howarth GS; Bleich A; Raber K; von Hörsten S; Holst JJ; Abbott CA
    Inflamm Bowel Dis; 2010 Aug; 16(8):1340-51. PubMed ID: 20186930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
    Juillerat-Jeanneret L
    J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice.
    Yazbeck R; Howarth GS; Geier MS; Demuth HU; Abbott CA
    Front Biosci; 2008 May; 13():6850-8. PubMed ID: 18508699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of glucagon-like peptides in inflammatory bowel diseases-current knowledge and future perspectives.
    Zatorski H; Sałaga M; Fichna J
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1321-1330. PubMed ID: 31359088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1.
    Duffy NA; Green BD; Irwin N; Gault VA; McKillop AM; O'Harte FP; Flatt PR
    Eur J Pharmacol; 2007 Jul; 568(1-3):278-86. PubMed ID: 17573070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dipeptidyl peptidase-4 inhibitor linagliptin attenuates inflammation and accelerates epithelialization in wounds of diabetic ob/ob mice.
    Schürmann C; Linke A; Engelmann-Pilger K; Steinmetz C; Mark M; Pfeilschifter J; Klein T; Frank S
    J Pharmacol Exp Ther; 2012 Jul; 342(1):71-80. PubMed ID: 22493041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilisation of the isobole methodology to study dietary peptide-drug and peptide-peptide interactive effects on dipeptidyl peptidase IV (DPP-IV) inhibition.
    Nongonierma AB; FitzGerald RJ
    Food Funct; 2015 Jan; 6(1):313-20. PubMed ID: 25477187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.